Can-Fite Share Price

Can-Fite Share Price

AMEX: CANF | Others
$1.47
+$1.47 (--%) Last updated on 20 Nov, 2026 | 01:46 IST
  • Performance
  • Chart
  • Corporate Actions
  • About
  • Price history
  • FAQs

Can-Fite Stock Performance

Open
$1.47
Prev. Close
N/A
Circuit Range
N/A
Day Range
$1.47 - $1.47
Year Range
$0.17 - $10.39
Volume
136
Average Traded
$1.47

Can-Fite Share Price Chart

Line chart of the Can-Fite price trend over the selected period. The price rose overall, ranging from 1.48 to 1.51, ending at 1.48.
$1.47$1.47
L
Show Current Price
H

Corporate Actions

Split
Ex-date: 05 Jan 2026

Split
Ex-date: 09 Jan 2023

Split
Ex-date: 10 May 2019

About Can-Fite

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Can-Fite Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.63
$1.47
-12.50%
Oct 2026
$2.20
$1.68
-24.32%
Sep 2026
$3.20
$2.22
-35.75%
Aug 2026
$3.52
$3.46
+5.66%
Jul 2026
$4.89
$3.27
+14.34%
Jun 2026
$3.25
$2.86
-16.37%
May 2026
$3.04
$3.42
+8.57%
Apr 2026
$3.18
$3.15
+1.61%
Mar 2026
$4.83
$3.10
-35.01%
Feb 2026
$4.14
$4.77
+17.78%
Jan 2026
$0.19
$4.05
+1,935.18%
Dec 2025
$0.34
$0.20
-43.30%

Can-Fite Share Price FAQs